Effectiveness of atorvastatin therapy in patients with arterial hypertension, diabetic nephropathy and diabetes mellitus type 2

  • O. M. Chernatska Sumy State University
  • T. S. Mazur Sumy State University
  • N. V. Demikhova Sumy State University
  • O. M. Vlasenko Kharkiv medical academy of postgraduate education
  • T. M. Rudenko Sumy State University
  • I. O. Forkert Sumy State University
Keywords: arterial hypertension; diabetic nephropathy; type 2 diabetes mellitus; atorvastatin; lipid profile

Abstract

The actual problem of internal medicine is the managemen of patients with comorbid pathology. Arterial hypertension (AH) is determined in about quarter of the population in the world. Moreover, the coexistence of AH and type 2 diabetes mellitus (DM) connected with the increased risk of cardiovascular complications (CVC) compared with patients with AH. In principle dyslipidemia is the common link between AH and type 2 DM, which need the correction. No doubt that reduction of atherogenic and increase of anti atherogenic lipoproteins is necessary for persons with comorbid pathology. The objective of our study was the assessment of atorvastatin treatment in patients with AH, diabetic nephropathy and type 2 DM. We obtained 96 patients with AH, diabetic nephropathy and type 2 DM (І group), 25 persons with AH (ІІ group), 15 conditionally healthy individuals. Persons had CVC in the past. For patients from the І and ІІ group CVC were defined accordingly (4,97 ± 0,20) years and (4,10 ± 0,05) years ago (P = 0,0291). The duration of AH is (8,1 ± 0,2) years for the І group and (8,90 ± 0,13) years for the ІІ group. The levels of lipid profile spectrum were determined according to the methods of W. T. Friedewald. The results of investigation were analyzed with the help of Microsoft Excel 2016. Correction of lipid profile spectrum is the important part of multipurpose treatment for persons with coexistent pathology. All patients were treated by atorvastatin (10−40 mg/day) during 6 months in a complex therapy. The target levels of general cholesterol during 6 months were presented in 30 persons (31.91 %), low density lipoproteids – in 10 persons (10.64 %), high density lipoproteids – in 26 persons (27.66 %), triglycerides – in 34 persons (36.17 %) among patients with AH, diabetic nephropathy and type 2 DM. In conclusion, it is advisable to prescribe atorvastatin (10–40 mg/day) for correction of dyslipidemia, reduction of proatherogenic orientation, prevention of atherosclerotic process manifestation and cardiovascular complications in patients with AH with diabetic nephropathy and type 2 diabetes mellitus.

Downloads

Download data is not yet available.

References

1. Mіtchenko O. І., Lutaj M. І. Dislіpіdemії: dіagnostika, profіlaktika ta lіkuvannya: Metod. rekomendacії asocіacії kardіologіv Ukraїni. – K., 2011. – 17 р.
2. Nakaz Mіnіsterstva ohoroni zdorovʼya vіd 24.05.2012 № 384. Onovlena ta adaptovana klіnіchna nastanova, zasnovana na dokazah.
3. Pan'kіv V. І. Korekcіya kardіorenal'nih chinnikіv riziku u hvorih na cukrovij dіabet 2 tipu // Lіki Ukraїni. – 2016. – Vip. 26, № 10. – S. 62−65.
4. Unіfіkovanij klіnіchnij protokol pervinnoї ta vtorinnoї (specіalіzovanoї) medichnoї dopomogi «Cukrovij dіabet 2-go tipu»: Nakaz Mіnіsterstva ohoroni zdorov’ya vіd 21.12.2012 r. № 1118. – 118 s.
5. Chogtu B., MagazineR., Bairy K. L. Statin use and risk of diabetes mellitus // World J. of Diabetes. – 2015. – Vol. 6, N 2. – P. 352−357.
6. Demikhova N., Chernatska O., Mazur T. et al. Markers of cardiovascular complications in patients with type 2 diabetes mellitus and arterial hypertension // Bangladesh J. of Med. Science. – 2018. – Vol. 17, N 2. – Р. 319–322.
7. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge // Clin. Chemistry. – 1972. – Vol. 18, N 6. – P. 499−502.
Pai J. K., Cahill L. E., Huetal F. B. Hemoglobin A1c Is Associated With Increased Risk of Incident Coronary Heart Disease Among Apparently Healthy, Non diabetic Men and Women // J.of the Am. Heart. Association. – 2013. – February. – P. 1−6.

Abstract views: 143
PDF Downloads: 166
Published
2019-03-26
How to Cite
Chernatska, O. M., Mazur, T. S., Demikhova, N. V., Vlasenko, O. M., Rudenko, T. M., & Forkert, I. O. (2019). Effectiveness of atorvastatin therapy in patients with arterial hypertension, diabetic nephropathy and diabetes mellitus type 2. Likars’ka Sprava, (1-2), 105-110. https://doi.org/10.31640/JVD.1-2.2019(15)
Section
Guide lines for the practitioner